BOLD - Your Daily Pharma Scoop: Karyopharm's NDA Accepted Audentes Data Positive
Welcome to the Daily Pharma Scoop, a daily feature from the creators of the Total Pharma Tracker, a popular biopharma Marketplace service here on Seeking Alpha. In the daily scoop, we focus in on one key investment concept from the biopharma space, and also provide quick commentary on other important news and a set of selected links to major news from the day before.
Karyopharm's (KPTI) selinexor is able to restore Velcade-sensitivity in penta-refractory treatment-resistant multiple myeloma. The FDA